Regulation of Proteasomal Function by Nicotine

尼古丁对蛋白酶体功能的调节

基本信息

  • 批准号:
    7361505
  • 负责人:
  • 金额:
    $ 15.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-01 至 2010-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Over a billion men, women and children worldwide smoke, and tobacco continues to be the largest single cause of premature death in developed countries. Nicotine, the main addictive component of tobacco, produces the neurophysiological, motivational and behavioural changes associated with nicotine addiction. Understanding the neuropharmacological, anatomical and behavioural underpinnings of the psychoactive effects of nicotine is key for the identification of new therapeutical targets and the development of new drugs against nicotine dependence. This proposal stems from recent data in the lab that pinpoint a novel mechanism of action for nicotine. We now show that the drug can change maturation and turnover of scaffolding proteins and neurotransmitter receptors by blocking proteasomal activity. Our data indicate that nicotine's effects on the proteasome occur via both nAChR-mediated and nAChR- independent mechanisms. These results provide a mechanism that could explain some of the effects of nicotine, including the drug-induced changes in protein levels, and nAChR upregulation. This exploratory grant will continue the characterization of the proteasome/nicotine interaction with both in vivo and in vitro mechanisms. To determine whether nicotine's influence on the proteasome is one of the mechanisms underlying the pharmacological effects of nicotine we will examine the behavioral effects of nicotine in mice in which proteasomal function is perturbed by proteasomal inhibitors or the inducible knockout of a proteasomal component. Other biochemical and pharmacological experiments will provide information on the nature of the nicotine/proteasome interaction. The investigation of nicotine's influence on the proteasome is important not only for the effects of nicotine on the brain but it will also provide new insights on the effects of tobacco on tissues and organs that do not express nAChRs.
描述(由申请人提供):全世界有十亿多人,妇女和儿童,烟草仍然是发达国家过早死亡的最大单一原因。尼古丁是烟草的主要成瘾成分,它会产生与尼古丁成瘾相关的神经生理,动机和行为变化。了解尼古丁的心理活性作用的神经药理学,解剖学和行为基础是鉴定新的治疗靶标和开发针对尼古丁依赖性的新药物的关键。该建议源于实验室中最新数据,该数据指出了尼古丁的新型作用机理。现在,我们表明该药物可以通过阻断蛋白酶体活性来改变脚手架蛋白和神经递质受体的成熟和周转。我们的数据表明,尼古丁对蛋白酶体的影响通过NACHR介导的和NACHR独立机制发生。这些结果提供了一种机制,可以解释尼古丁的某些作用,包括药物诱导的蛋白质水平变化和NACHR上调。该探索性赠款将继续表征蛋白酶体/尼古丁与体内和体外机制的相互作用。为了确定尼古丁对蛋白酶体的影响是尼古丁药理作用的基础机制之一,我们将检查尼古丁在尼古丁在蛋白酶体功能中受到蛋白酶体抑制剂的扰动或蛋白酶体成分诱导的敲除的行为作用。其他生化和药理学实验将提供有关尼古丁/蛋白酶体相互作用性质的信息。对尼古丁对蛋白酶体的影响的研究不仅对尼古丁对大脑的影响很重要,而且还将为烟草对不表达NACHR的组织和器官的影响提供新的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Mariella De Biasi的其他基金

Educating Physician Scientists in Psychiatry (EPSP): Firing up the next generation of translational and clinical neuroscientists
精神病学医师科学家教育 (EPSP):培养下一代转化和临床神经科学家
  • 批准号:
    10353376
    10353376
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Striatal mechanisms for e-cigarette reinforcement by flavorants
香料增强电子烟的纹状体机制
  • 批准号:
    10452636
    10452636
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Striatal mechanisms for e-cigarette reinforcement by flavorants
香料增强电子烟的纹状体机制
  • 批准号:
    10660974
    10660974
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Striatal mechanisms for e-cigarette reinforcement by flavorants
香料增强电子烟的纹状体机制
  • 批准号:
    10017928
    10017928
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Striatal mechanisms for e-cigarette reinforcement by flavorants
香料增强电子烟的纹状体机制
  • 批准号:
    10874294
    10874294
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Striatal mechanisms for e-cigarette reinforcement by flavorants
香料增强电子烟的纹状体机制
  • 批准号:
    10197866
    10197866
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Striatal mechanisms for e-cigarette reinforcement by flavorants
香料增强电子烟的纹状体机制
  • 批准号:
    10656610
    10656610
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Educating Physician Scientists in Psychiatry (EPSP): Firing up the next generation of translational and clinical neuroscientists
精神病学医师科学家教育 (EPSP):培养下一代转化和临床神经科学家
  • 批准号:
    10094259
    10094259
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Educating Physician Scientists in Psychiatry (EPSP): Firing up the next generation of translational and clinical neuroscientists
精神病学医师科学家教育 (EPSP):培养下一代转化和临床神经科学家
  • 批准号:
    10569533
    10569533
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Translational study on CHRNA5 variation and alcohol reward mechanisms
CHRNA5变异与酒精奖励机制的转化研究
  • 批准号:
    10413132
    10413132
  • 财政年份:
    2018
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:

相似海外基金

Resolving the mechanism of cofactor and substrate interactions with Cdc48
解决辅因子和底物与 Cdc48 相互作用的机制
  • 批准号:
    10201455
    10201455
  • 财政年份:
    2020
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Resolving the mechanism of cofactor and substrate interactions with Cdc48
解决辅因子和底物与 Cdc48 相互作用的机制
  • 批准号:
    10434738
    10434738
  • 财政年份:
    2020
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Mechanisms of Lis1 and NudE/L Regulation of the Molecular Motor Dynein
Lis1 和 NudE/L 分子运动动力蛋白的调节机制
  • 批准号:
    10374042
    10374042
  • 财政年份:
    2018
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Mechanisms of Lis1 and NudE/L Regulation of the Molecular Motor Dynein
Lis1 和 NudE/L 分子运动动力蛋白的调节机制
  • 批准号:
    9762944
    9762944
  • 财政年份:
    2018
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别:
Mechanisms of Lis1 and NudE/L Regulation of the Molecular Motor Dynein
Lis1 和 NudE/L 分子运动动力蛋白的调节机制
  • 批准号:
    10132347
    10132347
  • 财政年份:
    2018
  • 资助金额:
    $ 15.35万
    $ 15.35万
  • 项目类别: